Tech Company Financing Transactions
ViewRay Funding Round
F-Prime Capital, OrbiMed and Aisling Capital participated in a $25 million Series B funding round for ViewRay. The funding round was announced on 1/22/2008.
Transaction Overview
Company Name
Announced On
1/22/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors
Proceeds Purpose
"This substantial funding from blue-chip biomedical investors is a first in our industry and a testament to the promise of ViewRay's technology to help cancer patients. More importantly, it allows us to accelerate the development of our system, the first device to promise real-time volumetric imaging simultaneous with radiation treatment" explained ViewRay CEO William Wells.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
2 Thermo Fisher Way
Oakwood Village, OH 44146
USA
Oakwood Village, OH 44146
USA
Phone
Website
Email Address
Overview
ViewRay (OTC: VRAY) sells a patent pending Renaissance race System 1000 that combines two proven technologies: magnetic resonance imaging (MRI) and gamma ray radiotherapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Scott Drake
Chief Financial Officer
Ajay Bansal
Chief Medical Officer
Martin Fuss
Chief Operating Officer
Shar Matin
Chief Scientific Officer
James Dempsey
VP - General Counsel
Robert McCormack
VP - Human Resources
Robert Fuchs
Browse more venture capital transactions:
Prev: 1/22/2008: Greenplum venture capital transaction
Next: 1/22/2008: LifeLock venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs